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Abstract: The beneficial effects of the Mediterranean diet (MD) adherence in reducing cardiovascular
disease (CVD) risk and improving CVD-related physiological indices have been well-documented.
However, the exact MD adherence duration needed for these effects to occur is under-researched. The
aim of the present, two-arm, two-site study clinical trial was to assess the effects of long- vs. short-term
MD adherence on the skin microvascular circulation, and quality of life. Two groups were recruited,
one being long-term MD adherers (>5 years; from Greece; control group), and one of the non-adherers
(from the UK), with the latter participating in a four-week MD intervention (intervention group).
Our main outcome was skin microvascular function assessed by cutaneous vascular conductance
(CVC). Secondary outcomes included quality of life, dietary intake, blood pressure and lipidemic
profile. At the end of the intervention, both groups had high MD adherence. For the intervention
group, significantly improved post-intervention CVC values were noted concerning the initial peak
phase (2.0 ± 0.6 vs. 2.8 ± 0.8; p < 0.05). CVC values of the control group, were however higher at
the plateau phase in comparison to the intervention group (intervention end; 3.8 ± 0.8 vs. 3.1 ± 1.2;
p < 0.05). As per QoL, the physical domain was improved post-intervention (13.7 ± 1.2 vs. 15.9 ± 1.2;
p < 0.05). No differences were observed in the lipidemic profile between groups, or between the
baseline and final intervention phases. The findings indicate that although short-term MD adherence
is effective in improving certain microvascular physiological properties and QoL domains, there is
room for additional improvement, observed in long-term adherers. Our findings are important in the
design of future, MD-based, lifestyle interventions, with the advisable durations differing between
target groups.
Keywords: Mediterranean diet; microcirculation; quality of life; cardiovascular disease; dietary
intervention; nutrition therapy; clinical trial
1. Introduction
Cardiovascular disease (CVD) is the biggest preventable cause of mortality in the western world [1].
Interestingly, despite treatment innovations and efficacy, the number of people who are either at risk,
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or suffering from any CVD form is following an increasing trend, year-by-year [2]. Therefore, the
importance of reducing CVD and CVD risk remains high. Lifestyle interventions either based on
diet [3], exercise [4], or in combination [5], have been proposed as a means for improving cardiovascular
health in clinical and healthy-but-at-risk populations. Amongst those, the ones that markedly stand
out are based on the Mediterranean diet (MD) model [5–8]. The MD is a collective term for the
dietary patterns consumed by the people inhabiting the Mediterranean countries. It involves increased
consumption of olive oil, vegetables, legumes, oily fish, cheese, nuts and moderate amounts of white
meat and wine [9,10]. MD appears to provide clinical benefits in reducing the risk for CVD, diabetes
and cancer [7]. Although the MD benefits are considered to be significant, there are certain aspects
that need further clarification—for example, it is not known as of whether the improved physiological
effects in skin microvascular health from the long-term adherence to the MD are greater to those
observed following a short-term adherence (as someone would expect them to be) and if they are, to
what extent. This is important, as it is now known that changes in the skin endothelial function, mirror
if not precede those observed in large arteries [11]. Consequently, knowing the effects of an MD-based
dietary intervention on skin microcirculation, may well influence clinicians’ recommendations and
public health policies involving MD as a "healthy diet" option, because it will determine the duration
of periods of full implementation and maintenance that should be targeted for. It will also help in
determining whether there are limitations to the benefits offered by the MD alone, and if additional
lifestyle arms (e.g., exercise, sedentary behavior reduction, etc.) would be necessary to achieve a
greater CVD risk-reduction target. In this context, the present study was designed aiming to define the
effects of short-term MD adherence on CVD risk using as a proxy endothelial dysfunction, compared to
long-term MD adherence, among healthy, sedentary, adult populations. We hypothesized that people
adhering to the MD for longer would have a better endothelial function, defined by NO-bioavailability
and axon reflex indicators (see Methods and Materials section). Additional outcomes included changes
in the quality of life (QoL), anthropometry and blood lipid profile. For the purpose of the study, we
recruited one Mediterranean (Greek) population that has followed the MD for a long period of time
(>5 years) and for which MD is part of their culinary traditions (control group), and one population
residing far from the Mediterranean sea (British), that has followed the MD for a short time period (4
weeks), without being previously accustomed to it (intervention group).
2. Methods and Materials
2.1. Study Design and Ethics
This was a two-centre (Sheffield, UK and Thessaloniki, Greece), parallel-arm, open-label
intervention trial. The protocol was approved by the Sheffield Hallam University Ethics
Review Committee (HWB-2016-17-S&E-44) and the Aristotle University of Thessaloniki Research
Ethics Committee (251/26.2.18). The protocol was registered at the Thai Clinical Trials Registry
(TCTR20190305002), via the World Health Organization trials registry platform. All experiments
complied with the current laws of the countries in which they were performed, and all participants
provided written consent to participate in the study.
2.2. Study Population and Procedures
For the study, two population groups were recruited, one consisting of long-term MD adherers
(control group), recruited in Greece, and one of the non-adherers (intervention group), recruited in the
UK, scheduled for participation in an MD intervention. Both groups (18–75 years old) consisted of
healthy, sedentary adults (controls: Thessaloniki, Greece, n = 40, and intervention: Sheffield, UK, n =
34) (Table 1). Participants were recruited through local community groups, social and mass media and
word of mouth. Posters were placed around regional hospitals and university campuses.
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Table 1. Baseline characteristics of participants.
Control Group (n = 40) Intervention Group (n = 34)
Single visit Baseline 4 Weeks
Gender (Male/Female ratio) (n) 29/11 11/23 *
Age (years) 37 ± 11 40 ± 17
Height (cm) 171 ± 9 169 ± 1
IPAQ Sitting Time (min) 480 ± 270 475 ± 120 465 ± 118
Body Weight (kg) 68.9 ± 15.1 72.0 ± 12.9 71.0 ± 11.3
BMI (kg/m2) 23.4 ± 4.6 25.2 ± 6.1 24.6 ± 5.5
Waist circumference (cm) 78 ± 15 81 ± 9 80 ± 8
Waist/hip ratio 0.65 ± 0.1 0.66 ± 0.1 0.64 ± 0.2
Physical activity occupational category
(sedentary/low/moderate/intense) (n) 28/8/4/0 24/7/1/0
Calf circumference (cm) 49 ± 6 51 ± 6 50 ± 5
Resting heart rate (bpm) 70 ± 10 69 ± 8 68 ± 7
Resting SBP (mm Hg) 120 ± 11 118 ± 12 117 ± 11
Resting DBP (mm Hg) 78 ± 8 75 ± 11 74 ± 10
Body Fat (% of body weight) 30.0 ± 9.0 29.0 ± 9.0 28.1 ± 8.2
BMI: Body mass index; bpm: Beats per minute; DBP: Diastolic blood pressure; IPAQ: International Physical Activity
Questionnaire; IQR: Interquartile range; SBP: Systolic blood pressure; SD: Standard Deviation. Data are presented
as n, mean ± SD, or IQR (range). * Significantly different between groups (p < 0.05).
Inclusion criteria were: (1) Being an adult; (2) abstaining from any medication that could influence
cardiovascular function; (3) being willing to participate; (4) adhering to the MD for over five years
(self-reported; control group); and (5) MD non-adherence (intervention group). The 5-year cut-off
for the control group was used, as it was considered that it would be sufficientfor the long-term MD
benefits to be established.
Exclusion criteria were: (1) Participation in regular physical exercise (>60 min/week of structured or
planned physical activity; known to affect positive microvascular integrity); (2) diagnosis of any chronic
disease that could affect vascular function (e.g., diabetes, CVD, and hypertension); (3) pregnancy; and
(4) smoking. No financial incentives were given to any of the participants to increase participation.
A flowchart of the recruitment, screening and study procedures performed in each group is
presented in Figure 1. Following the provision of written consent, controls were invited to the Medical
School, Faculty of Health Sciences of the Aristotle University of Thessaloniki for a single, 70-min
session. In parallel, screening for participation in the intervention group took place at the Centre for
Sport and Exercise Science of Sheffield Hallam University for an identical set of baseline assessments.
The intervention group then followed the MD for four weeks, after which, all measurements were
repeated. Participants in both groups were asked to refrain from drinking caffeinated drinks for a
period of three hours prior to the assessments.
2.2.1. Mediterranean Diet Adherence
MD adherence was assessed with the MEDAS questionnaire, a validated MD adherence
screener [12] that has been previously used on the Greek population [13]. The MEDAS assesses
the frequency of intake of specific food-groups associated with the MD, including olive oil, wine,
vegetables and fruits, legumes, fish and shellfish against the frequency of intake of food groups
associated with a more westernized diet regime, like sweets and candies, animal fat, carbonated
beverages, red meat, etc. A score greater than 6 indicates increased MD adherence, and subsequently,
a score of less than 6 reflects MD non-adherence. Subsequently, a MEDAS score >6 was a selection
criterion for the Greek cohort and a MEDAS <6 for the UK sample. This way, the Greek sample
consisted of long-term MD adherers and the UK cohort of non-adherers who would participate in
the short-term MD intervention protocol. For a more thorough dietary assessment, each participant
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also completed a 48h dietary recall questionnaire [14] for each study visit, with controls completing
one dietary recall and participants in the intervention group completing one at baseline and one
post-intervention. Collected data were entered into a dietary analysis software, which incorporated the
“McCance and Widdowson’s UK Composition of Food Database” [15] within its databank (Nutritics
Ltd., Version 1.7, Dublin, Ireland).
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mean value being used (left arm; Dinamap Dash 2500, GE Healthcare, USA). Finger‐prick blood‐
capillary samples were also obtained using a Cholestec LDX system (Alere Cholestech LDX® system; 
Alere Inc., San Diego, CA, USA) to determine values for Total Cholesterol (TC), High Density 
Lipoprotein (HDL) and TC/HDL, as previously described [8]. 
2.2.4. Physiological Measures of CVD Risk—Laser Doppler Flowmetry (LDF)  
For the purposes of this study, we concentrated on endothelial dysfunction, as it is a common 
phenomenon of all major CVD risk factors (e.g., high blood cholesterol, hypertension, diabetes, etc.). 
To determine cutaneous microvascular function, we used LDF, combined with local heating of the 
skin, as previously described in the literature [3]. This allows us to obtain information primarily on 
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2.2.2. Physical Activity Levels, Anthropometry and Quality of Life
Physical activity levels were assessed as metabolic equivalents of task minutes via the International
Physical Activity Questionnaire-SF (IPAQ) [16], to ensure that all participants met the sedentary
requirements set for the study. Measured anthropometric indices included height, weight, calf and
waist circumference measured, as well as the calculation of body mass index (as body weight (kg)/height
(m)2. QoL was assessed via the WHOQoL-BREF [17] questionnaire in the Greek (control group) and
English language (intervention group) [16,18].
2.2.3. Blood Lipid Profile and Arterial Blood Pressure
Participants’ gender was recorded, and heart rate (HR), systolic (SBP) and diastolic blood pressure
(DBP) were measur d after 15 minutes of rest, three times, at one-minute intervals, with the mean
value b ing used (left arm; Din map Dash 2500, GE Healthcare, USA). Finger-prick blood-capillary
samples were also obtained using a Cholestec LDX system (Aler Cholestech LDX®system; Alere Inc.,
S n Diego, CA, USA) to determine values for Total Cholesterol (TC), High Density Lipoprotein (HDL)
and TC/HDL, as pr viously described [8].
2.2.4. Physiological Measures of CVD Risk—Laser Doppler Flowmetry (LDF)
For the purposes of this study, we concentrated on endothelial dysfunction, as it is a common
phenomenon of all major CVD risk factors (e.g., high blood cholesterol, hypertension, diabetes, etc.).
To determine cutaneous microvascular function, we used LDF, combined with local heating of the
skin, as previously described in the literature [3]. This allows us to obtain information primarily on
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neurone-mediated axon reflex function (initial peak; [19]) and NO bioavailability (secondary rise and
plateau phase; [19]). Tests in both groups were conducted in temperature-controlled rooms, with an
ambient temperature of 22–24 ◦C, as previously described by our lab [3]. Tests in all participants were
undertaken in the upper right forearm in skin sites without visible veins, body hair, and damaged or
irritated skin. The testing site was sterilized, and then the LDF probe was attached to the skin. Local
thermal hyperemia was induced using a heating disk (Model 455, Perimed AB) connected to a heating
unit (Model 5020, Perimed AB). LDF signals were recorded using PeriSoft for Windows 9.0 software
(PeriSoft for Windows 2.50; Perimed AB). During each test, the resting HR and blood pressure were
recorded from the left arm at regular intervals using a patient monitoring device (Dinamap Dash 2500,
GE Healthcare, Florence, SC, USA). The LDF assessment protocol began with the recording of baseline
skin blood flow data for a 5 min period with the local heating disk temperature being set at 32 ◦C. Then,
in order to induce rapid local heating, the temperature of the probe was increased by 1 ◦C every 10 s
until the local heating disk reached 42 ◦C, which was maintained for a period of 25 min. Then the test
was concluded, with the temperature being rapidly increased to 44 ◦C for the final 10 min, to support
the assessment of maximal vasodilation. Measurement phases were then defined (Table 2). The LDF
values divided by the corresponding mean arterial pressure to give the cutaneous vascular conductance
(CVC) in arbitrary perfusion units (APU)/mm Hg. The mean arterial pressure was calculated from
SBP and DBP. The data presented as raw CVC and CVC was normalized to maximum (%CVCmax =
((CVC/CVCmax) × 100)). The resting HR and BP of participants were calculated from the average of
measured HR and BP throughout the LDF recording period.
Table 2. Laser Doppler flowmetry measurement phase definition.
Measurement Phase: Time Point:
Baseline The arithmetical mean of the last 2 min of the first 5 min period.
Initial peak The arithmetical mean of the highest consecutive 30-s period withinthe distinct initial hyperemic response.
Plateau The arithmetical mean of the last 2 min of heating at 42 ◦C.
Maximum The arithmetical mean of the last 2 min of heating at 44 ◦C.
2.2.5. Mediterranean Diet Intervention
Intervention group participants were given a food “starter” pack that included amongst others
brown rice, brown pasta, lentils, olive oil, nuts, chopped tomatoes and tomato puree. They were also
given an information booklet, guidelines on which foods constitute the MD, and a recipe booklet to
support the transition of their current diet to the MD prototype. The research team also created and
moderated an “invitation-only” social media group, to support intervention group participants, in
addition to the provision of extensive support via regular phone-calls and e-mail exchange. To achieve
a low attrition rate, we used our ‘six pillars of adherence’ framework, based upon ‘social support’,
‘education’, ‘reachability’, ‘small groups intervention implementation’, ‘reminders’, and ‘simplicity’,
which has been previously applied with excellent results in lifestyle interventions (achieving more
than 90% of retention and 79% of completion rates) i.e., [3,4].
2.3. Statistical Analysis
For our sample size calculations we used commercial software (G*Power 3.1.7, HHU of Düsseldorf),
using initial peak CVC as the primary outcome and data from our previous studies [3]: For an estimated
difference of 0.6 AU/mmHg between groups and an estimated standard deviation of 0.9 AU/mmHg,
we calculated that we would need 34 people per group. Over-recruitment was implemented in the
control group, to account for any last-minute cancellations and avoid missing recruitment targets
within our designated timeframe.
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Independent t-tests were performed on physical characteristics (stature, body mass, BMI, systolic
and diastolic blood pressure), nutritional data (energy Intake, carbohydrates, protein, total fat, saturated
fat, MUFA, PUFA, olive oil, fruit, vegetables, and fiber), raw CVC and %CVCmax (baseline, initial
peak, and plateau), WHOQoL, IPAQ sitting time, MEDAS score and lipidemic profile (TC, HDL, and
TC/HDL) data between groups. Dependent t-tests were performed to determine pre-to-post changes
for the intervention group. To satisfy normality, logarithmic transformations were undertaken for
several variables (carbohydrate and saturated fat intake, BMI, TC/HDL, baseline %CVCmax and initial
peak %CVCmax). Where homogeneity of variance or normality could not be assumed (i.e., in raw CVC
initial peak and plateau (pre-intervention), and initial peak %CVCmax), the Mann–Whitney U test was
undertaken to assess between-groups comparisons; the Wilcoxon signed-rank test was performed for
within-group analyses.
Statistical analysis was performed using SPSS (IBM SPSS Statistics Version 22 (IBM United
Kingdom Limited, Hampshire, UK). Statistical significance for the test was set at p ≤ 0.05. Values are
presented as mean ± standard deviation (SD), unless otherwise stated.
3. Results
3.1. Anthropometric and Physical Activity Measures
No differences were observed in the BMI, height, weight, fat mass, resting HR, SBP, calf and waist
circumferences, waist/hip ratio, or IPAQ measures either between groups, or for the intervention group,
pre- and post-intervention (Table 1). However, a different gender ratio was recruited in the two groups.
3.2. MD Adherence and Dietary Components
The dietary intake of each group is summarized in Table 3. Mean MEDAS score increased
significantly in the intervention group (p < 0.05) at the intervention end. Moreover, a between-groups
comparison suggests that at the intervention end, the intervention group was more compliant to the
MD than the control group (p < 0.05; Table 3). At the intervention end, controls consumed more MUFAs
(p < 0.05), total fat (p < 0.05), saturated fat (p < 0.05) and olive oil (p < 0.05). They also consumed fewer
carbohydrates, without reaching statistical significance. On the other hand, the intervention group
consumed more fiber and proteins (p < 0.05; Table 3).
Table 3. Dietary intake and compliance with the Mediterranean diet between groups and time-points
(mean ± SD).
MD Adherence, Food-Group and
Nutrient Intake
Control Group (n = 40) Intervention Group (n = 34)
Single Visit Baseline 4 Weeks
MEDAS score 9 ± 1 5 ± 1 11 ± 1 *,++
Energy Intake (kcal/day) 1742 ± 353 1865 ± 323 1732 ± 432
Carbohydrates (g/day) 155 ± 45.6 213 ± 33 172.3 ± 55 *
Fiber (g/day) 17.9 ± 8.4 17.0 ± 6.1 23.5 ± 7.2 *,++
Protein (g/day) 56.7 ± 18.7 70.5 ± 20.5 74.6 ± 20.1 ++
Fat (g/day) 102.8 ± 21.5 86 ± 21 71 ± 23 *,++
Saturated fat (g/day) 24.2 ± 8.2 32.0 ± 7.5 20 ± 9.1 *,+
MUFA (g/day) 62.4 ± 11.0 27.2 ± 9.0 32.3 ± 9.5 +
PUFA (g/day) 12.0 ± 4.3 11.9 ± 4.4 13.0 ± 6.5
Olive oil (servings/day) 4.5 ± 0.5 0.4 ± 0.4 2.1 ± 1.5 *,++
Fruit and vegetables (servings/day) 7.2 ± 2.1 3.3 ± 2 6.9 ± 3.3 *
* p < 0.05 within groups; ++ p < 0.01 and + p < 0.05 between groups. Data presented as mean ± SD. For olive
oil, serving is calculated as tablespoon, for fruits and vegetables as 80 g. Between groups comparison assesses
differences between the control group, and the intervention group at the end of the trial. MD: Mediterranean diet;
MEDAS: Mediterranean diet adherence screener; MUFA: Mono-unsaturated fatty acids; PUFA: Poly-unsaturated
fatty-acids; SD: Standard deviation.
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3.3. Cutaneous Vascular Conductance
Baseline values remained unchanged between visits for the intervention group. No
statistically-significant differences were observed between the control and intervention groups
(intervention end).
For initial peak, raw CVC values were significantly improved at the end of the 4-weeks, for the
intervention group (p < 0.05; Table 4), while no statistically-significant differences were observed
following a between-groups comparison. However, the between-groups comparison revealed a
statistically-significant difference for %CVCmax, with the intervention group reaching a higher
percentage of their maximum CVC value at that point (p < 0.05; Table 4).
Table 4. Microcirculatory results between long- and short-term Mediterranean diet adherers (mean ± SD).
Measure
Control Group (n = 40) Intervention Group (n = 34)
Single Visit Baseline 4 Weeks
Baseline CVC (APU/mmHg) 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.2
Initial peak CVC (APU/mmHg) 2.7 ± 0.6 2.0 ± 0.6 2.8 ± 0.8 +
Plateau CVC (APU/mmHg) 3.8 ± 0.8 2.2 ± 0.6 3.1 ± 1.2 *
Baseline CVCmax (%) 3.0 ± 2.3 8.9 ± 5.2 7.3 ± 8.5 *
Initial peak CVCmax (%) 56.7 ± 8.2 73.1 ± 15.2 75.5 ± 16.1 *
Plateau CVCmax (%) 79.4 ± 9.6 86.1 ± 16.2 82.8 ± 9.7
APU: Arbitrary perfusion units; CVC: Cutaneous vascular conductance; SD: Standard deviation. * p < 0.001 for the
between groups’ comparison. + p < 0.05 for the intervention group comparison between time-intervals.
For the plateau stage, the raw CVC of the control group was significantly higher to that of the
intervention group (intervention end values; p < 0.001; Table 4). No statistically-significant differences
were observed for %CVCmax, either between-groups or for the intervention group before and after
the intervention.
3.4. Quality of Life and Lipidemic Profile
No differences were noted between groups, with the exception of the social domain (p < 0.05). An
improvement was also observed at the end of the intervention among intervention group participants,
with regards to the physical domain (p < 0.05) (Table 5). No differences were observed either
between-groups, or in the intervention group between the two study visits concerning the lipidemic
profile of the sample (Table 5).
Table 5. Quality of life and Lipidemic profile of participants in both groups (mean ± SD).
Variables
Control Group (n = 40) Intervention Group (n = 34)
Baseline Baseline 4 weeks
QoL domains
Physical 16.2 ± 1.8 13.7 ± 1.4 15.9 ± 1.2 +
Psychological 15.5 ± 2.3 13.9 ± 1.8 14.4 ± 2.3
Social 15.6 ± 2.2 * 13.1 ± 3.9 14.6 ± 1.7
Environmental 13.9 ± 1.9 13.3 ± 1.6 13.7 ± 1.6
Lipidemic profile
TC (mmol/L) 4.1 ± 1.1 4.1 ± 0.6 4.2 ± 0.6
HDL (mmol/L) 1.6 ± 0.7 1.4 ± 0.5 1.5 ± 0.3
TC/HDL (ratio) 2.8 ± 1.1 3.6 ± 1.9 3.0 ± 0.9
* p < 0.05 for between groups comparison; ‡ p < 0.05 within group comparison. Data presented as mean ± SD.
Between groups comparison assessed differences between the control and intervention group at the end of the
trial. HDL: High-density cholesterol; MD: Mediterranean Diet; QoL: Quality of Life; SD: Standard Deviation; TC:
Total cholesterol.
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4. Discussion
The present study is the first to compare endothelial microvascular physiology and QoL between
long- and short-term exposure to the MD. The results showed that short-term MD adherence is
effective in ameliorating selected markers of endothelial function and QoL domains among MD-naïve
participants. Although the MD-imposed microcirculatory benefits are well-described for medium [5]
and short-term [3] compliance of the MD, we are yet to establish if longer-term consumption can bring
additional microvascular physiological benefits. This knowledge would be important to tailor therapies
for certain diseases or conditions; for example, a reduction in the production of nitric oxide (NO) has
been associated with higher CVD risk [20], while it is known that ageing has an effect on vascular
tone, maintaining the axon-mediated vascular vasodilation and NO production [21]. Therefore, if for
instance short-term MD adherence can induce benefits on NO bioavailability, but not on the vascular
tone, then this would probably mean that longer-term interventions would be more appropriate for
older or other clinical populations, for which the vascular physiology is similarly affected (e.g., systemic
sclerosis) [22].
4.1. Quality of Life
Our findings suggest that the study participants in both groups maintain a happy and healthy life
with improvements being noticed in the intervention group at the end of the intervention. Participants
in the control group in particular, tend to score better in the WHOQoL compared to the average values
of the Greek population reported by other studies, at the majority of domains (i.e., physical domain:
16.2 (1.8) vs 15.2 (2.2); [21]), while the UK cohort matching those at the end of the intervention [21].
Although the overall quality of life is affected by an array of parameters (including demographic,
developmental, psychological, and biological ones) [23], it can be argued that any observed changes
in a particular domain can be attributed to a specific parameter that changed, if the others remain
unaltered. Our study confirms the general notion derived from MD-based work [7] and studies based
on other “healthy” diets [24] that a “healthy” dietary regime brings higher scores for health-related
QoL, with particular benefits on physical and emotional well-being [24].
This is the first study, undertaken in a community-setting, to suggest that QoL benefits are prompt
to appear, only four weeks after the adoption of the MD. This is an important finding, considering that
the adaptation to a new dietary regime is not an easy process, and there are many challenges (financial,
habitual and societal) to be faced by all parties involved [25], despite the fact that in most cases those
adapting do recognize the benefits that come with it [26]. Our findings, therefore, can be used as a
supporting element for both dieticians/nutritionists who make the suggestion for the dietary change to
the MD and those at the receiving end, but also for those involved in public health policy making.
4.2. Compliance to the MD
Our study verified that the MD diet could be adopted and adhered to by MD-naive,
non-Mediterranean populations [27]. Our results suggest that the intervention group participants
managed to adapt themselves to the new diet quite quickly and successfully between the two visits
(Table 2). Nevertheless, it appears the type of MD that they consumed was different to the one followed
by our long-term group participants, being abundant in proteins and fiber, with less fat, despite the
statistically-significant increase noted in the olive oil consumption (Table 3). On the other hand, the
control group consumed more fat, primarily due to the greater intake of virgin olive oil, which affects
the MUFA intake [28]. These differences under the MD dietary pattern, cannot be considered as a
surprise: It is well accepted that such variations do exist, and that MD is a collective term of multiple
dietary protocols with similar ingredients at varying amounts [10,29]. Although the comparison
between populations consuming the MD and the use of different methods of measuring adherence is a
highly-debated topic [25,30], we can be confident that both groups followed a similar dietary pattern,
albeit with some differences in the fat sub-types’ intake. Furthermore, it is accepted that habitual
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MD consumption in the Mediterranean region is usually associated with greater PUFA and MUFA
intake [31] and therefore, such a finding should have been expected by a Greek population, like the
controls group herein.
According to the latest representations, the MD food pyramid also includes regular physical
activity and adequate rest, whereas, in our study, only sedentary participants were considered eligible,
in an effort to control for this factor [32,33]. Thus, it should be expected that in a more “pragmatic”
clinical trial, including more appropriate physical activity patterns, the effects of MD adherence would
be further improved in several endpoints, including the QoL [34].
4.3. Microvascular Function
This is the first study to suggest that although a short-term lifestyle intervention based on the
MD can bring quick benefits in regards to the axon-reflex microcirculatory function (as is described by
an improvement in “initial peak” stage), an improvement in NO bioavailability (as this is described
by “plateau” stage) is not also observed, and remains statistically-lower to the values observed in the
control (long-term MD adherers) group. It can be argued that the statistically-significant observed
differences, may not be solely due to the difference in the duration of the consumption of the MD
between the two groups, but also due to the different constitution of the MD. Indeed, recent evidence
suggests that that the high intake of MUFA (which was the case for our longer-term population)
comes with greater cardioprotective properties [28] and can lower CVD risk especially in high-risk
populations [35]. This would on this own, probably reflect positively at microcirculatory function.
Nevertheless, our control group did have a high saturated fat intake -markedly larger to the one
received by the short-term population- which in turn is known to increase CVD risk [31,35] and affect
circulatory function at all levels. In that case, considering that: (a) Plant- and sea-derived PUFA also
have cardioprotective properties [31,36]; and (b) it is quite improbable that the protective benefits of
MUFA can cancel out the saturated fats’ negative ones completely, it is tempting to postulate that the
differences between the two groups can primarily be attributed to the difference between the duration
of the consumption of the MD. Unfortunately, a further breakdown of the participants’ consumption
patterns to quantify green vegetable intake was not accounted for when designing the protocol herein.
Thus, we ought to consider that increased green vegetable intake might also induce improvements
in the NO profile of the Greek cohort, as suggested [37,38]. Further interventional studies, in which
groups will be followed for longer-term periods will be able to confirm this postulation.
Our findings may have an implication in the way and the duration that MD-based lifestyle
interventions are prescribed in clinical and pre-clinical groups. For example, in T2DM [39] and systemic
sclerosis [22,40], microcirculatory changes are more prominent in the axon-reflex. Therefore, it makes
sense that for these populations, we have at least a short-term MD intervention (ideally in combination
with other lifestyle elements, such as exercise and smoking cessation) to be advised to introduce
quicker physiological benefits. The advice, however, would be different in older populations (clinical
or not), since it is well-accepted that ageing has a two-fold, negative effect on both microcirculatory
NO production and axon-reflex vasodilation. For those populations, a longer-term strategy would be
more appropriate, having the added-benefit of the MD-associated, systemic physiological benefits [39].
4.4. Experimental Considerations
Despite its importance, our study also has a number of limitations. Due to operational difficulties,
it was not possible to have an equal ratio of genders in the two study groups. This might have had an
effect on the CVD risk between the two groups given the different phenotypes associated with distinct
ethnic backgrounds [41]. However, both groups have a very good match regarding most of their main
characteristics. Additionally, it was not possible to have baseline assessments for the control group.
This would have required a larger amount of resources to the ones that our study had. Further studies
may address this limitation. We also used 2-d diet diaries instead of the gold standard 7-d weight food
diary. We opted for that choice to reduce participants’ burden and reduce likely dropouts/complete
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recruitment within our limited time period. Moreover, this remains a validated collection method of
dietary data.
Additionally, it should be mentioned that some of the exerted beneficial health effects might also
be due to the overall Mediterranean lifestyle, including adequate sun exposure and increased vitamin
D synthesis, and not to the diet per se [42,43]. This is an important point to consider when accounting
for environmental factors that might affect the results in the intervention arm. Finally, although our
sample was recruited through advertising, it may not be representative of either the Greek or the
British population. Nevertheless, our findings can be considered as indicative, paving the way for a
larger, longer-term trial.
5. Conclusions
Our work is the first to compare the skin microvascular and QoL effects between long- and
short-term exposures to the MD. Our findings suggest that although MD brings quick benefits
concerning axon-reflex mediated vasodilation (which might be sufficient for certain clinical populations,
such as T2DM and systemic sclerosis), longer interventions are required for the full range of
microcirculatory physiological benefits to be experienced. At the same time, however, QoL benefits
are experienced within a relatively short period (four weeks), which may prove decisive for all those
attempting (and struggling) to accustom themselves in a new, culturally different dietary regime.
Additionally, the present study paves the way for further research of longer duration, in both clinical
and healthy populations.
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